南京远淑医药科技有限公司

南京远淑医药科技有限公司

江苏省南京市栖霞区仙林大学城纬地路9号江苏生命科技创新园F7栋404-408，309-313

2015

20至29

不愿意公开

      南京远淑医药科技有限公司成立于2015年位于历史文化名城-南京，作为医药及电子材料相关的高科技企业，已于2018年底通过国家高科技术企业认定并荣获江苏省民营科技企业、ISO9001国际质量管理体系认证企业、江苏好技术等殊荣。南京远淑医药目前在中国南京江苏生命科技创新园拥有超过约500余平米的研发中心，拥有完善的国际先进的仪器设备和管理体系及职能部门。公司专注于定制合成CRO以及定制加工CMO，研发团队拥有专业的工艺开发队伍，对客户的定制项目遵循严格保密制度和知识产权保护制度。公司目前拥有抗癌新药的开发（相关专利2篇）及医药中间体专利（2篇）。材料领域主要为第二代锂电池核心电解质以及超级电容（相关专利10篇）；电子级环氧树脂的研发（专利1篇）；阻燃剂1篇。公司的理念是坚持科技创新才是企业发展的源动力！我们将努力成为医药以及材料领域的专业生产商和供应商。  

经验丰富的研发人员,发货速度,生产能力,合同定制,接受买家的规格要求,良好的信誉,优质服务

210033

制造商

北美洲,东欧,亚洲

Arotinolol intermediate(52560-89-1);Epinastine intermediate (41218-84-2);Pranlukast intermediate(30131-16-9);Pranlukast intermediate(13633-25-5);Cilostazol intermediate (54197-66-9);Cilostazol intermediate (73963-42-5);4-Cyanobenzoic acid(619-65-8);2-Bromo-1-(4-fluorophenyl)-2-phenylethanone(88675-31-4);4,4'-Bis(methoxymethyl)-1,1'-biphenyl(3753-18-2);Mizoribine intermediate(62009-47-6);Tosufloxacin intermediate(100491-29-0);Tosufloxacin intermediate(103831-11-4);Alectinib intermediate (1256584-73-2);Ivoriglitazone intermediate(1415477-23-4);Sarpogrelate hydrochloride intermediate(167145-13-3);MEA（211184-47-3）;DL-Bornane-2,3-dione (10373-78-1);Alverine citrate(5560-59-8);Aminomalonic acid diethyl ester hydrochloride(13433-00-6);3-Hydroxypyrazine-2-carboxamide(55321-99-8);4-Fluorobenzoylacetonitrile(4640-67-9);Pyronaridine intermediate(6626-40-0);Pyronaridine intermediate(85236-51-7);Mevalonic lactone(674-26-0);Sotorasib intermediate（113237-20-0）;Sotorasib intermediate（1698293-93-4）;Sotorasib intermediate（147081-29-6）;Sotorasib intermediate（1534369-41-9）;Gonadotropin releasing hormone (GnRH) intermediate（239087-08-2）;Gonadotropin releasing hormone (GnRH) intermediate（1454273-40-5）;Gonadotropin releasing hormone (GnRH) intermediate（1454273-42-7）;Gonadotropin releasing hormone (GnRH) intermediate（17515-77-4）;Gonadotropin releasing hormone (GnRH) intermediate（102089-75-8）;5-Aminolevulinic acid（106-60-5）;Methyl 4-fluorobenzoylacetate（63131-29-3）;3-(2-fluoro-phenyl)-3-oxo-propionic acid methyl ester（185302-86-7）;Mebikar（10095-06-4）;Palmitoylethanolamide（544-31-0）;2,3-Dihydrobenzo[b]furan-5-ylamine（42933-43-7）;Methotrexate intermediate（73978-41-3）;Methotrexate intermediate（945-24-4）;Methotrexate intermediate（82778-08-3）;Methotrexate intermediate（52853-40-4）;Methotrexate intermediate（2378-95-2）;Azilsartan（147403-03-0）;BMI intermediate(29305-46-2);BMI intermediate(17057-04-4);Cetyl-PG hydroxyethyl palmitamide (110483-07-3);YS-2-010 A liquid curing agent suitable for epoxy resin curing systems;YS-2-008 A latent epoxy resin curing accelerator primarily used in epoxy- anhydride systems;YS-2-001 Latent curing agent specifically designed for one-component epoxy resin curing systems;Melam (3576-88-3);Trigonelline（535-83-1）;Homarine (445-30-7);YS-2-003 A flexible epoxy resin,low total chlorine content, low viscosity;YS-2-007 An amino resin with end groups consisting of amino or aniline groups;YS-2-011 An aqueous polymer dispersion and emulsion designed for metal coatings;YS-2-800 A water-based polymer dispersion/emulsion;MPPE Novel thermosetting oligomeric polyphenylene ether (PPE) resin;PEB, 1,4-bis(epoxyethyl)benzene, is a type of DVBDO compound. Its polymers hold significant application potential in epoxy grouting materials and packaging materials;PAF is a low-viscosity, high-purity, and highly functional amino resin.;Melem (1502-47-2)

第二十三届世界制药原料中国展

2025-03-06至2025-07-31

E10D15

Intermediates & Fine Chemicals;CMO & CRO